Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer.
Journal: NPJ breast cancer
Published: March 05, 2026
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study.
Journal: Breast cancer research and treatment
Published: February 13, 2025
Cost-Utility Analysis of Multigene Assays to Guide Treatment Decisions for Node-Negative Early Breast Cancer.
Journal: Oncology and therapy
Published: August 08, 2024
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal Perspective.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: January 17, 2024
The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective.
Journal: Journal of medical economics
Published: July 19, 2023
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer.
Journal: Breast cancer research and treatment
Published: November 17, 2022
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer.
Journal: Breast cancer research : BCR
Published: June 28, 2022
Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
Journal: Annals of surgical oncology
Published: March 29, 2022
Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer.
Journal: Annals of surgical oncology
Published: May 11, 2021
Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer.
Journal: Journal of the National Cancer Institute
Published: November 30, 2020
Last Updated: 09/26/2026